187 related articles for article (PubMed ID: 11384567)
1. Potential mechanism for the additivity of pilocarpine and latanoprost.
Toris CB; Zhan GL; Zhao J; Camras CB; Yablonski ME
Am J Ophthalmol; 2001 Jun; 131(6):722-8. PubMed ID: 11384567
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: a comparison of 1 and 6 weeks of treatment.
Johnson TV; Fan S; Zhan G; Camras CB; Toris CB
J Glaucoma; 2010 Aug; 19(6):356-64. PubMed ID: 20179619
[TBL] [Abstract][Full Text] [Related]
3. Latanoprost and cholinergic agonists in combination.
Toris CB; Alm A; Camras CB
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S141-7. PubMed ID: 12204711
[TBL] [Abstract][Full Text] [Related]
4. Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes.
Toris CB; Camras CB; Yablonski ME
Ophthalmology; 1993 Sep; 100(9):1297-304. PubMed ID: 8371915
[TBL] [Abstract][Full Text] [Related]
5. Effect of pilocarpine 4% in combination with latanoprost 0.005% or 8-iso prostaglandin E2 0.1% on intraocular pressure in laser-induced glaucomatous monkey eyes.
Serle JB; Wang RF; Mittag TW; Shen F; Podos SM
J Glaucoma; 2001 Jun; 10(3):215-9. PubMed ID: 11442186
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group.
Nordmann JP; Söderström M; Rouland JF; Malecaze F
Br J Ophthalmol; 2000 Feb; 84(2):181-5. PubMed ID: 10655195
[TBL] [Abstract][Full Text] [Related]
7. Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure.
Toris CB; Zhan G; Fan S; Dickerson JE; Landry TA; Bergamini MV; Camras CB
J Glaucoma; 2007 Mar; 16(2):189-95. PubMed ID: 17473728
[TBL] [Abstract][Full Text] [Related]
8. The influence of Latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: a double-masked placebo-controlled clinical study.
Dinslage S; Hueber A; Diestelhorst M; Krieglstein G
Graefes Arch Clin Exp Ophthalmol; 2004 Aug; 242(8):654-60. PubMed ID: 15241610
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study.
Lim KS; Nau CB; O'Byrne MM; Hodge DO; Toris CB; McLaren JW; Johnson DH
Ophthalmology; 2008 May; 115(5):790-795.e4. PubMed ID: 18452763
[TBL] [Abstract][Full Text] [Related]
10. Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients.
Toris CB; Camras CB; Yablonski ME
Am J Ophthalmol; 1999 Jul; 128(1):8-14. PubMed ID: 10482088
[TBL] [Abstract][Full Text] [Related]
11. Effects of apraclonidine on aqueous humor dynamics in human eyes.
Toris CB; Tafoya ME; Camras CB; Yablonski ME
Ophthalmology; 1995 Mar; 102(3):456-61. PubMed ID: 7891985
[TBL] [Abstract][Full Text] [Related]
12. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
Bucci MG
J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
[TBL] [Abstract][Full Text] [Related]
13. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.
Wang RF; Gagliuso DJ; Mittag TW; Podos SM
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4143-7. PubMed ID: 17724199
[TBL] [Abstract][Full Text] [Related]
14. Diurnal and nocturnal variations in aqueous humor dynamics of patients with ocular hypertension undergoing medical therapy.
Gulati V; Fan S; Zhao M; Maslonka MA; Gangahar C; Toris CB
Arch Ophthalmol; 2012 Jun; 130(6):677-84. PubMed ID: 22332206
[TBL] [Abstract][Full Text] [Related]
15. Effects of brimonidine on aqueous humor dynamics in human eyes.
Toris CB; Gleason ML; Camras CB; Yablonski ME
Arch Ophthalmol; 1995 Dec; 113(12):1514-7. PubMed ID: 7487618
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes.
Serle JB; Podos SM; Kitazawa Y; Wang RF
Jpn J Ophthalmol; 1998; 42(2):95-100. PubMed ID: 9587840
[TBL] [Abstract][Full Text] [Related]
17. Increase in outflow facility with unoprostone treatment in ocular hypertensive patients.
Toris CB; Zhan G; Camras CB
Arch Ophthalmol; 2004 Dec; 122(12):1782-7. PubMed ID: 15596580
[TBL] [Abstract][Full Text] [Related]
18. Additive effect of unoprostone and latanoprost in patients with elevated intraocular pressure.
Aung T; Chew PT; Oen FT; Chan YH; Thean LH; Yip L; Lim BA; Soh J; Seah SK
Br J Ophthalmol; 2002 Jan; 86(1):75-9. PubMed ID: 11801508
[TBL] [Abstract][Full Text] [Related]
19. A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension.
Aung T; Chew PT; Yip CC; Chan YH; See JL; Khng CG; Hoh ST; Ng LH; Lee HM
Am J Ophthalmol; 2001 May; 131(5):636-42. PubMed ID: 11336940
[TBL] [Abstract][Full Text] [Related]
20. Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye.
Sponsel WE; Mensah J; Kiel JW; Remky A; Trigo Y; Baca W; Friberg T
Am J Ophthalmol; 2000 Aug; 130(2):151-9. PubMed ID: 11004288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
